Optimal evaluation involves biomarker assessment (plasma glutathione, oxidative stress markers), genetic screening for glutathione synthesis pathway variants, and clinical history of conditions associated with glutathione depletion
JCI insight 4 , e132975 (2019)
Global Clinical Trials: Men interested in PT-141 might also seek out clinical trials
Approval: 1960 Indications and Usage for Spironolactone Oral Suspension Spironolactone oral suspension is an antagonist of aldosterone indicated for: the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure ( 1.1) use as an add-on therapy for the treatment of hypertension, to lower blood pressure
Aim for 12 pounds per week
Discuss any medication additions with your PlexusDx provider to ensure no interactions